Subscribe

ProPhase Labs, Inc. (PRPH)

USD0.06 +0.00 (+0.67%)
US NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
Address 711 Stewart Avenue 11530
Garden City, NY, US
CEO Ted William Karkus
IPO 1994-04-04
CIK 868278 ISIN US74345W2070

Explore sections of this company profile

Description

ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.06 +0.00 (+0.67%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
83.4K
Beta
0.07
Float Shares
4.32M
Free Float %
91.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-21.43% +10.00% -8.33% -21.43% -91.54% -75.56% -96.92% -99.74% -99.58% -99.57% -95.60%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (2 ratings, all time) Buy
Price Targets & DCF
Current price
0.06
Low 140.00 +232,458.1%
Consensus 140.00 +232,458.1%
Median 140.00 +232,458.1%
High 140.00 +232,458.1%
Ratings Trend (MoM)
Rating 2025-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 1
140.00
+232,458.1%
Quality scores
Altman Z-Score
-3.64
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    -35.8% Q1'26: -66.6% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    +93.3% Q1'26: -120.5% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -426.1% Q1'26: -156.5% (vs Q1'25)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -378.7% Q1'26: +0.0% (vs Q1'25)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -136.7% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +344.9% Q1'26: +545.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    -0.76× Q1'26: -0.91× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.07) × ERP
WACC = 10% × Ke + 90% × Kd (80.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.06
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2000
actual
Dec 2001
actual
Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Revenue
19.36M
est: 20.48M (-5.4%)
24.67M
est: 35.25M (-30.0%)
14.51M
est: 14.00M (+3.7%)
79.04M
est: 62.50M (+26.5%)
122.65M
est: 121.34M (+1.1%)
44.38M
est: 17.97M (+147.0%)
6.77M
est: 13.02M (-48.0%)
4.35M
est: 21.36M (-79.7%)
41.69M
41.69M – 41.69M
+95.2% YoY
EBITDA
-5.35M
est: -127.51M (+95.8%)
64.2K
est: -4.05M (+101.6%)
-1.49M
est: -2.96M (+49.8%)
11.39M
est: 4.49M (+153.7%)
28.73M
est: 4.86M (+491.5%)
-14.83M
est: -7.03M (-110.9%)
-32.34M
est: -5.09M (-535.0%)
-11.40M
est: -8.35M (-36.4%)
-16.31M
-16.31M – -16.31M
-95.2% YoY
EBIT
-5.71M
est: -134.08M (+95.7%)
569.2K
est: -6.03M (+109.4%)
-2.02M
est: -3.78M (+46.6%)
6.45M
est: 1.50M (+329.0%)
23.67M
est: 1.08M (+2,088.6%)
-21.53M
est: -7.94M (-170.9%)
-38.98M
est: -5.76M (-577.3%)
-16.45M
est: -9.44M (-74.3%)
-18.43M
-18.43M – -18.43M
-95.2% YoY
Net Income
-5.20M
est: -127.51M (+95.9%)
216.0K
est: -4.05M (+105.3%)
-2.13M
est: -2.19M (+3.1%)
6.27M
est: 1.52M (+311.5%)
18.46M
est: -4.37M (+522.8%)
-16.78M
est: -12.38M (-35.6%)
-53.36M
est: -107.81M (+50.5%)
-14.74M
est: -47.54M (+69.0%)
88.29M
88.29M – 88.29M
+285.7% YoY
SGA
18.23M
est: 31.06M (-41.3%)
14.15M
est: 53.46M (-73.5%)
7.95M
est: 21.24M (-62.6%)
22.49M
est: 29.79M (-24.5%)
46.41M
est: 34.98M (+32.6%)
34.50M
est: 41.28M (-16.4%)
37.89M
est: 29.90M (+26.7%)
19.32M
est: 49.05M (-60.6%)
95.75M
95.75M – 95.75M
+95.2% YoY
EPS
-4.90
est: 0.07 (-7,638.5%)
0.20
est: -0.09 (+322.2%)
-2.00
est: -0.12 (-1,639.1%)
4.10
est: 0.15 (+2,574.0%)
11.70
est: 1.12 (+944.6%)
-9.80
est: -1.46 (-572.0%)
-26.10
est: -12.70 (-105.5%)
-1.74
est: -5.60 (+68.9%)
10.40
10.40 – 10.40
+285.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-05 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-06-04 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-06-03 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-06-02 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-06-01 D+ 1/5 1/5 1/5 1/5 1/5 1/5 1/5
2026-05-28 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-27 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-26 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-22 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-21 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-20 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-19 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-18 D+ 1/5 1/5 1/5 1/5 1/5 1/5 2/5
2026-05-15 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-14 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-13 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-12 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-11 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-08 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-07 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-25.22M
OE per share TTM
-6.89
Owner's Yield
-5,518.98%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
21.1%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
31
Total invested
1.39M
Insider transactions (90d)
0
Beneficial owners (>5%)
9
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Ted Karkus 4.27M 24.90% IN United States 2022-10-18
2 Guy 2.84M 19.40% 2.45M 394.7K 2.45M IN USA 2010-12-15
3 Mark Leventhal 1.06M 6.20% 882.0K 180.0K 882.0K 10.00 IN United States 2017-01-27
4 Karkus 620.9K 4.80% 620.9K 620.9K 10.00 IN USA 2009-04-07
5 BML Investment Partners, L.P. 298.3K 2.70% 298.3K 298.3K PN Delaware 2018-01-30
6 DeShazo 277.0K 2.10% 277.0K 277.0K 10.00 IN USA 2009-04-07
7 Leventhal 240.0K 1.90% 240.0K 240.0K 10.00 IN USA 2009-04-07
8 Burnett 151.5K 1.20% 151.5K 151.5K 10.00 IN USA 2009-04-07
9 Gleckel, MD 20.0K 0.10% 20.0K 20.0K 10.00 IN USA 2009-04-07

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q3
Investors holding
31
-3 vs prev Q
New positions
7
Closed positions
10
Increased
14
Reduced
5
Put/Call ratio
0.00
Calls held
13.7K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 ACCRETIVE WEALTH PARTNERS, LLC -250.0K (-100.0%) -114.5K (-100.0%) 0.00% -0.602 pp 0.00% -0.035 pp USD 2 qtrs SOLD
2 ANNEX ADVISORY SERVICES, LLC -15.0K (-100.0%) -6.9K (-100.0%) 0.00% -0.036 pp 0.00% 0.000 pp USD 2 qtrs SOLD
3 APOLLON WEALTH MANAGEMENT, LLC -182.5K (-100.0%) -83.5K (-100.0%) 0.00% -0.439 pp 0.00% -0.002 pp USD 2 qtrs SOLD
4 BANK OF AMERICA CORP /DE/ -1.1K (-100.0%) -511.0 (-100.0%) 0.00% -0.003 pp 0.00% +0.000 pp USD 19 qtrs SOLD
5 BANK OF NEW YORK MELLON CORP -37.1K (-100.0%) -17.0K (-100.0%) 0.00% -0.089 pp 0.00% +0.000 pp USD 51 qtrs SOLD
6 BARCLAYS PLC -11.8K (-100.0%) -28.5K (-100.0%) 0.00% -0.028 pp 0.00% +0.000 pp USD 7 qtrs SOLD
7 BLACKROCK, INC. -28.0K (-100.0%) -12.8K (-100.0%) 0.00% -0.068 pp 0.00% +0.000 pp USD 6 qtrs SOLD
8 CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. -14.8K (-100.0%) -7.0K (-100.0%) 0.00% -0.036 pp 0.00% +0.000 pp USD 2 qtrs SOLD
9 CHAPIN DAVIS, INC. -80.0K (-100.0%) -36.6K (-100.0%) 0.00% -0.193 pp 0.00% -0.009 pp USD 12 qtrs SOLD
10 CORECAP ADVISORS, LLC -100.0 (-100.0%) -46.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 8 qtrs SOLD
11 FARTHER FINANCE ADVISORS, LLC -97.0 (-100.0%) -44.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 13 qtrs SOLD
12 FORVIS WEALTH ADVISORS, LLC -19.6K (-100.0%) -9.0K (-100.0%) 0.00% -0.047 pp 0.00% 0.000 pp USD 3 qtrs SOLD
13 GEODE CAPITAL MANAGEMENT, LLC -302.9K (-100.0%) -138.7K (-100.0%) 0.00% -0.729 pp 0.00% +0.000 pp USD 21 qtrs SOLD
14 HIGHTOWER ADVISORS, LLC -237.3K (-100.0%) -108.7K (-100.0%) 0.00% -0.571 pp 0.00% 0.000 pp USD 10 qtrs SOLD
15 JANE STREET GROUP, LLC -13.7K (-100.0%) -6.3K (-100.0%) 0.00% -0.033 pp 0.00% +0.000 pp USD 2 qtrs SOLD
16 JPMORGAN CHASE & CO -1.8K (-100.0%) -808.0 (-100.0%) 0.00% -0.004 pp 0.00% +0.000 pp USD 6 qtrs SOLD
17 KEY FINANCIAL INC -1.0 (-100.0%) -1.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
18 MORGAN STANLEY -9.2K (-100.0%) -4.2K (-100.0%) 0.00% -0.022 pp 0.00% +0.000 pp USD 33 qtrs SOLD
19 NORDWAND ADVISORS, LLC -10.0K (-100.0%) -4.6K (-100.0%) 0.00% -0.024 pp 0.00% -0.001 pp USD 4 qtrs SOLD
20 NORTHERN TRUST CORP -23.2K (-100.0%) -10.6K (-100.0%) 0.00% -0.056 pp 0.00% +0.000 pp USD 48 qtrs SOLD
21 RENAISSANCE TECHNOLOGIES LLC -10.1K (-100.0%) -4.6K (-100.0%) 0.00% -0.024 pp 0.00% +0.000 pp USD 63 qtrs SOLD
22 SBI SECURITIES CO., LTD. -504.0 (-100.0%) -231.0 (-100.0%) 0.00% -0.001 pp 0.00% +0.000 pp USD 5 qtrs SOLD
23 SIMPLEX TRADING, LLC -40.6K (-100.0%) -18.0K (-100.0%) 0.00% -0.098 pp 0.00% +0.000 pp USD 17 qtrs SOLD
24 STATE STREET CORP -44.7K (-100.0%) -20.4K (-100.0%) 0.00% -0.108 pp 0.00% +0.000 pp USD 19 qtrs SOLD
25 SUSQUEHANNA INTERNATIONAL GROUP, LLP -397.9K (-100.0%) -182.2K (-100.0%) 0.00% -0.958 pp 0.00% +0.000 pp USD 8 qtrs SOLD
26 SYKON CAPITAL LLC -644.8K (-100.0%) -295.2K (-100.0%) 0.00% -1.552 pp 0.00% -0.098 pp USD 6 qtrs SOLD
27 TWO SIGMA SECURITIES, LLC -47.5K (-100.0%) -21.7K (-100.0%) 0.00% -0.114 pp 0.00% -0.003 pp USD 6 qtrs SOLD
28 UBS GROUP AG -19.7K (-100.0%) -9.0K (-100.0%) 0.00% -0.048 pp 0.00% +0.000 pp USD 8 qtrs SOLD
29 VANGUARD GROUP INC -531.9K (-100.0%) -243.6K (-100.0%) 0.00% -1.281 pp 0.00% +0.000 pp USD 63 qtrs SOLD
30 WELLS FARGO & COMPANY/MN -1.5K (-100.0%) -700.0 (-100.0%) 0.00% -0.004 pp 0.00% +0.000 pp USD 20 qtrs SOLD
31 XTX TOPCO LTD -28.8K (-100.0%) -13.2K (-100.0%) 0.00% -0.069 pp 0.00% -0.001 pp USD 3 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
500.0K
Shares disposed
Cash buys
Cash sales
Net activity
+500,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-09-09 Karkus Ted William Director / Officer A-Award A warrants 500,000 0.60 300.0K 500,000 D
2025-06-20 Abenante Carolina Director 0 0.00 0
2025-02-17 Hollenshead Stuart Officer A-Award A Option (right to buy) 500,000 0.60 300.0K 500,000 D
2025-02-14 Hirsch Warren Director A-Award A Option (right to buy) 100,000 0.60 60.0K 100,000 D
2025-02-14 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 100,000 0.60 60.0K 100,000 D
2025-01-27 Hollenshead Stuart Officer 0 0.00 0
2024-03-17 Karkus Ted William Director / Officer / 10% Owner A-Award A Option (right to buy) 400,000 6.00 2.40M 400,000
2024-03-17 Hirsch Warren Director A-Award A Option (right to buy) 70,000 6.00 420.0K 70,000
2024-03-17 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 70,000 6.00 420.0K 70,000
2024-03-17 Barr Jason Michael Director A-Award A Option (right to buy) 70,000 6.00 420.0K 70,000
2024-01-01 Latkin Jed Director A-Award A Option (right to buy) 500,000 6.00 3.00M 500,000
2023-06-19 Hirsch Warren Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-06-19 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-06-19 Barr Jason Michael Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-06-16 Hirsch Warren Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-06-16 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-06-16 Barr Jason Michael Director A-Award A Option (right to buy) 40,000 7.31 292.4K 40,000
2023-04-05 Karkus Ted William Director / Officer / 10% Owner G-Gift D Common Stock, par value $0.005 50,000 0.00 3,433,750
2023-04-04 Morse Robert A. Jr. Officer A-Award A Option (right to buy) 50,000 9.00 450.0K 50,000
2023-04-03 Karkus Ted William Director / Officer / 10% Owner G-Gift D Common Stock, par value $0.005 100,000 0.00 3,483,750
2023-02-01 Karkus Ted William Director / Officer / 10% Owner F-InKind D Common Stock, par value $0.005 268,337 8.18 2.19M 3,583,750
2023-01-13 Morse Robert A. Jr. Officer D Stock Option (Right to Buy) 50,000 12.01 600.5K
2023-01-13 Karkus Ted William Officer M-Exempt A Common Stock, par value $0.005 600,000 0.60 360.0K 3,671,318
2022-10-16 Karkus Ted William Officer M-Exempt A Common Stock, par value $0.005 600,000 0.60 360.0K 3,388,609
2022-08-10 Karkus Ted William Officer M-Exempt A Common Stock, par value $0.005 600,000 0.60 360.0K 3,105,214
2022-07-01 Hirsch Warren Director A-Award A Option (right to buy) 40,000 0.00 40,000
2022-07-01 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 40,000 0.00 40,000
2022-07-01 Barr Jason Michael Director A-Award A Option (right to buy) 40,000 0.00 40,000
2022-05-23 White Billy Joe Officer D Stock Option (Right to Buy) 400,000 6.74 2.70M 0
2022-05-23 Karkus Ted William Officer F-InKind D Common Stock, par value $0.005 278,257 8.47 2.36M 2,505,214
2022-05-23 Brady Monica L. Officer M-Exempt D Option (right to buy) 25,000 2.15 53.8K 0
2022-03-10 Barr Jason Michael Director P-Purchase A Common Stock, par value $0.0005 721 6.48 4.7K 30,962
2021-06-09 Hirsch Warren Director A-Award A Option (right to buy) 50,000 5.28 264.0K 50,000
2021-06-09 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 100,000 5.28 528.0K 100,000
2021-06-09 Barr Jason Michael Director A-Award A Option (right to buy) 100,000 5.28 528.0K 100,000
2021-06-03 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.005 33,943 5.07 171.9K 2,333,471
2021-05-07 Karkus Ted William Director / Officer / 10% Owner G-Gift A Common Stock, par value $0.005 60,000 0.00 100,000
2020-09-10 Hirsch Warren Director A-Award A Option (right to buy) 50,000 2.83 141.5K 50,000
2020-09-10 GLECKEL LOUIS MD Director A-Award A Option (right to buy) 100,000 2.83 283.0K 100,000
2020-09-10 Barr Jason Michael Director A-Award A Option (right to buy) 50,000 2.83 141.5K 50,000
2020-08-16 Brady Monica L. Officer A-Award A Option (right to buy) 150,000 2.64 396.0K 150,000
2020-08-13 Karkus Ted William Director / Officer / 10% Owner S-Sale D Common Stock, par value $0.005 50,000 2.75 137.5K 2,419,528
2020-08-13 GLECKEL LOUIS MD Director P-Purchase A Common Stock, par value $0.0005 50,000 2.75 137.5K 273,840
2020-07-09 Karkus Ted William Director / Officer / 10% Owner G-Gift D Common Stock, par value $0.005 54,150 0.00 2,469,528
2020-07-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 7,878 1.43 11.3K 223,840
2020-07-01 Barr Jason Michael Director A-Award A Common Stock, par value $0.0005 4,727 1.43 6.8K 30,241
2020-04-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 6,068 1.85 11.2K 215,962
2020-04-01 Barr Jason Michael Director A-Award A Common Stock, par value $0.0005 3,641 1.85 6.7K 25,514
2020-03-26 Karkus Ted William Director / Officer / 10% Owner S-Sale D Common Stock, par value $0.005 100,000 1.75 175.0K 2,549,528
2020-03-26 GLECKEL LOUIS MD Director P-Purchase A Common Stock, par value $0.0005 100,000 1.75 175.0K 209,894
2020-01-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 5,564 2.02 11.2K 109,894
2020-01-01 Barr Jason Michael Director A-Award A Common Stock, par value $0.0005 2,782 2.02 5.6K 21,873
2019-11-20 Brady Monica L. Officer A-Award A Option (right to buy) 100,000 2.01 201.0K 100,000
2019-10-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 5,740 1.96 11.3K 104,330
2019-10-01 Barr Jason Michael Director P-Purchase A Common Stock, par value $0.0005 2,870 1.96 5.6K 19,091
2019-08-15 Barr Jason Michael Director P-Purchase A Common Stock, par value $0.0005 2,500 2.05 5.1K 16,221
2019-08-14 Barr Jason Michael Director P-Purchase A Common Stock, par value $0.0005 6,000 2.05 12.3K 13,721
2019-07-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 4,727 2.38 11.3K 98,590
2019-05-22 Hirsch Warren Director 0 0.00 0
2019-04-03 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 3,571 3.15 11.2K 93,863
2019-01-02 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 3,583 3.14 11.3K 90,292
2018-12-04 Brady Monica L. Officer A-Award A Option (right to buy) 50,000 3.18 159.0K 50,000
2018-10-01 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 3,737 3.01 11.2K 86,709
2018-10-01 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 3,737 3.01 11.2K 318,282
2018-07-19 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 3,737 3.01 11.2K 82,972
2018-07-19 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 3,737 3.01 11.2K 314,545
2018-05-15 Karkus Ted William Director / Officer / 10% Owner M-Exempt D Employee Stock Option (right to buy) 100,000 1.65 165.0K 0
2018-02-23 Karkus Ted William Director / Officer / 10% Owner A-Award A Option (right to buy) 2,300,000 3.00 6.90M 2,300,000
2017-12-21 Karkus Ted William Director / Officer / 10% Owner S-Sale D Common Stock, par value $0.005 424,789 2.30 977.0K 2,484,849
2017-12-14 Karkus Ted William Director / Officer / 10% Owner M-Exempt A Common Stock, par value $0.005 600,000 1.00 600.0K 2,909,638
2017-10-02 Brady Monica L. Officer D Common Stock, par value $0.0005 0 0.00 7,400
2017-09-29 Leonard Braden Michael 10% Owner S-Sale D Common Stock 1,695,305 2.30 3.90M 627,322
2017-09-29 Karkus Ted William Director / Officer / 10% Owner S-Sale D Common Stock, par value $0.005 364,950 2.30 839.4K 2,309,638
2017-09-29 CUDDIHY ROBERT V JR Officer S-Sale D Common Stock, par value $0.005 358,621 2.30 824.8K 132,703
2017-09-29 Barr Jason Michael Director S-Sale D Common Stock, par value $0.005 4,379 2.30 10.1K 7,721
2017-09-14 CUDDIHY ROBERT V JR Officer M-Exempt D Employee Stock Option (right to buy) 40,000 1.39 55.6K 0
2017-04-27 Karkus Ted William Director / Officer / 10% Owner A-Award A Option (right to buy) 600,000 2.00 1.20M 600,000
2015-11-30 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 948 1.48 1.4K 881,980
2015-11-27 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 13,300 1.55 20.6K 881,032
2015-11-25 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 17,252 1.30 22.4K 867,732
2015-11-24 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 18,500 1.30 24.1K 850,480
2015-08-18 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 145,309 1.61 233.9K 832,180
2015-08-17 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 204,691 1.61 329.6K 686,671
2015-06-16 Barr Jason Michael Director D Common Stock, par value $0.0005 0 0.00 12,100
2015-06-08 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 71,471 1.40 100.1K 481,980
2015-06-05 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 128,529 1.31 168.4K 410,509
2015-06-04 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 200,000 1.30 260.0K 2,674,588
2015-05-19 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 199,504 1.35 269.3K 2,474,588
2015-05-18 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 10,496 1.34 14.1K 2,275,084
2015-01-02 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 3,147 0.00 31,829
2015-01-02 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 6,295 0.00 281,980
2015-01-02 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 6,295 0.00 79,235
2015-01-02 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 6,295 0.00 79,235
2015-01-02 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 6,295 0.00 310,808
2014-12-20 Karkus Ted William Director / Officer / 10% Owner A-Award A Common Stock, par value $0.0005 100,000 0.00 2,264,588
2014-12-20 CUDDIHY ROBERT V JR Officer A-Award A Option (right to buy) 40,000 1.39 55.6K 40,000
2014-11-07 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 13,946 1.38 19.2K 2,322,627
2014-11-06 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 7,500 1.37 10.3K 2,308,681
2014-11-05 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 43,300 1.32 57.2K 2,301,181
2014-10-09 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 169,975 1.30 221.1K 2,257,881
2014-10-08 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 114,910 1.30 149.2K 2,087,906
2014-10-02 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 16,900 1.40 23.6K 1,972,996
2014-09-24 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 4,538 1.40 6.4K 1,956,096
2014-09-23 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 16 1.38 22.08 1,951,558
2014-09-22 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 44,042 1.40 61.7K 1,951,542
2014-09-18 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 2,500 1.40 3.5K 1,907,500
2014-09-16 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 10,000 1.41 14.1K 1,905,000
2014-09-15 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 103,918 1.44 149.6K 1,895,000
2014-09-12 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 3,409 1.58 5.4K 1,791,082
2014-09-11 Leonard Braden Michael 10% Owner P-Purchase A Common Stock 14,613 1.53 22.4K 1,787,673
2014-09-10 Leonard Braden Michael 10% Owner I Common Stock 0 0.00 1,773,060
2013-12-19 Karkus Ted William Director / Officer / 10% Owner A-Award A Common Stock, par value $0.0005 50,000 0.00 1,664,588
2013-12-19 CUDDIHY ROBERT V JR Officer A-Award A Option (right to buy) 120,000 1.65 198.0K 120,000
2013-07-15 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 2,745 0.00 28,682
2013-07-15 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 5,490 0.00 275,685
2013-07-15 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 2,745 0.00 72,940
2013-07-15 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 2,745 0.00 72,940
2013-07-15 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 2,745 0.00 304,513
2013-06-25 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 155,480 1.58 245.7K 2,164,588
2013-06-24 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 286,150 1.56 446.4K 2,009,108
2013-06-23 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 58,370 1.51 88.1K 1,722,958
2013-05-23 Frank Mark Shawn Director P-Purchase A Common Stock, par value $0.0005 20,000 1.65 33.0K 70,195
2013-05-09 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 1,304 1.60 2.1K 180,000
2013-05-08 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 8,696 1.60 13.9K 178,696
2012-11-30 MCCUBBIN JAMES T Director P-Purchase A Common Stock, par value $0.0005 834 1.55 1.3K 25,937
2012-11-29 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 102,700 1.60 164.3K 150,000
2012-11-28 Leventhal Mark S Director P-Purchase A Common Stock, par value $0.0005 47,300 1.42 67.2K 47,300
2012-09-04 QUIGLEY GUY J 10% Owner S-Sale D Option (obligation to sell) 1 1.40 1.40 1
2012-05-17 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 103,402 1.05 108.6K 1,614,588
2012-05-15 Karkus Ted William Director / Officer / 10% Owner P-Purchase A Common Stock, par value $0.0005 141,388 0.98 138.6K 1,511,186
2012-01-11 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 10,757 0.00 131,324
2011-12-14 Karkus Ted William Director / Officer / 10% Owner A-Award A Common Stock, par value $0.0005 134,409 0.00 1,369,798
2011-12-14 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 33,603 0.00 120,567
2011-11-16 Karkus Ted William Director / Officer P-Purchase A Common Stock, par value $0.0005 19,192 0.90 17.3K 1,235,389
2011-11-14 Karkus Ted William Director / Officer P-Purchase A Common Stock, par value $0.0005 171,018 0.85 145.7K 1,216,197
2011-11-14 Burnett Mark A. Director P-Purchase A Common Stock, par value $0.0005 100,000 0.87 86.5K 301,768
2011-10-12 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 15,665 0.00 86,964
2011-10-07 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 5,640 0.00 25,103
2011-10-07 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 11,280 0.00 290,195
2011-10-07 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 11,280 0.00 70,195
2011-10-07 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 11,280 0.00 50,195
2011-10-07 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 11,280 0.00 201,768
2011-08-23 Burnett Mark A. Director P-Purchase A Common Stock, par value $0.0005 100 0.85 85.00 190,488
2011-07-12 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 5,460 0.00 19,463
2011-07-12 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 10,925 0.00 278,915
2011-07-12 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 10,925 0.00 58,915
2011-07-12 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 10,925 0.00 38,915
2011-07-12 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 15,170 0.00 71,299
2011-07-12 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 10,925 0.00 190,388
2011-04-21 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 3,620 0.00 14,003
2011-04-21 Karkus Ted William Director / Officer A-Award A Common Stock, par value $0.0005 128,571 0.00 883,349
2011-04-13 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 7,235 0.00 267,990
2011-04-13 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 7,235 0.00 47,990
2011-04-13 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 7,235 0.00 27,990
2011-04-13 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 10,050 0.00 56,129
2011-04-13 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 7,235 0.00 179,463
2011-01-31 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 3,590 0.00 10,383
2011-01-31 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 7,175 0.00 260,755
2011-01-31 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 7,175 0.00 40,755
2011-01-31 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 7,175 0.00 20,755
2011-01-31 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 7,175 0.00 172,228
2011-01-28 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 9,968 0.00 46,079
2010-12-15 Karkus Ted William Director / Officer A-Award A Option (right to buy) 600,000 1.00 600.0K 600,000
2010-12-15 CUDDIHY ROBERT V JR Officer A-Award A Option (right to buy) 200,000 1.00 200.0K 200,000
2010-12-14 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 9,811 0.00 36,111
2010-11-17 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 3,533 0.00 6,793
2010-11-16 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 7,065 0.00 253,580
2010-11-16 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 7,065 0.00 165,053
2010-11-12 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 7,065 0.00 33,580
2010-11-12 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 7,065 0.00 13,580
2010-10-01 QUIGLEY GUY J 10% Owner S-Sale D Common Stock, $.0005 par value per share 1,000 1.11 1.1K 2,441,559
2010-07-22 Burnett Mark A. Director A-Award A Common Stock, par value $0.0005 6,515 0.00 157,988
2010-07-15 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 9,045 0.00 26,299
2010-07-13 Leventhal Mark S Director A-Award A Common Stock, par value $0.0005 6,515 0.00 246,515
2010-07-13 Frank Mark Shawn Director A-Award A Common Stock, par value $0.0005 6,515 0.00 6,515
2010-07-13 DeShazo John Director A-Award A Common Stock, par value $0.0005 6,515 0.00 283,515
2010-07-12 MCCUBBIN JAMES T Director A-Award A Common Stock, par value $0.0005 3,260 0.00 3,260
2010-07-12 GLECKEL LOUIS MD Director A-Award A Common Stock, par value $0.0005 6,515 0.00 26,515
2010-04-08 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 6,250 0.00 17,254
2010-02-24 CUDDIHY ROBERT V JR Officer A-Award A Common Stock, par value $0.0005 4,418 0.00 4,418
2009-07-15 CUDDIHY ROBERT V JR Officer 0 0.00 0
2009-06-12 MCCUBBIN JAMES T Director 0 0.00 0
2009-06-12 Frank Mark Shawn Director 0 0.00 0
2009-04-06 Karkus Ted William 10% Owner D Common Stock 0 0.00 620,850
2007-09-21 QUIGLEY GUY J Director / Officer / 10% Owner M-Exempt A Common Stock, $.0005 par value per share 70,000 0.81 56.9K 2,586,559
2006-10-26 QUIGLEY GUY J Director / Officer / 10% Owner S-Sale D Common Stock, $.0005 par value per share 50,000 6.00 300.0K 2,446,559
2006-10-26 PHILLIPS CHARLES A Director / Officer / 10% Owner S-Sale D Common Stock, $.0005 par value per share 50,000 6.00 300.0K 1,011,706
2006-10-26 LONGO GEORGE J Director / Officer C-Conversion A Common Stock, $.0005 par value per share 50,000 2.50 125.0K 90,000
2006-05-08 QUIGLEY GUY J Director / Officer / 10% Owner S-Sale D Common Stock, $.0005 par value per share 25,000 10.00 250.0K 2,446,559
2006-05-08 PHILLIPS CHARLES A Director / Officer / 10% Owner C-Conversion A Common Stock, $.0005 par value per share 25,000 2.50 62.5K 1,036,706
2006-04-05 QUIGLEY GUY J Director / Officer / 10% Owner S-Sale D Common Stock, $.0005 par value per share 194,750 8.50 1.66M 394,705
2006-04-05 PHILLIPS CHARLES A Director / Officer / 10% Owner C-Conversion D Class E Warrants (Right to Buy) 290,125 1.75 507.7K 0
2006-03-21 QUIGLEY GUY J Director / Officer / 10% Owner C-Conversion A Common Stock, $.0005 par value per share 5,250 1.75 9.2K 5,250
2006-03-21 PHILLIPS CHARLES A Director / Officer / 10% Owner C-Conversion D Class E Warrants (Right to Buy) 9,875 1.75 17.3K 290,125
2005-12-12 WOUCH STEPHEN W Director A-Award A Options to Purchase Common Stock 20,000 13.80 276.0K 20,000
2005-12-12 Tormey Terrence O Director A-Award A Options to Purchase Common Stock 20,000 13.80 276.0K 20,000
2005-12-12 SCHAUM ROUNSEVELLE W Director A-Award A Options to Purchase Common Stock 20,000 13.80 276.0K 20,000
2005-12-12 QUIGLEY GUY J Director / Officer / 10% Owner A-Award A Options to Purchase Common Stock 100,000 13.80 1.38M 100,000
2005-12-12 PHILLIPS CHARLES A Director / Officer / 10% Owner A-Award A Options to Purchase Common Stock 80,000 13.80 1.10M 80,000
2005-12-12 LONGO GEORGE J Director / Officer A-Award A Options to Purchase Common Stock 40,000 13.80 552.0K 40,000

Executive team

Top executives
EBIT / Employee
-1.7K
Shares Outstanding
4.74M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2024 Ted Karkus Chief Executive Officer 675.0K 200.0K 1.22M 28.2K 2.12M 57.46%
2 2024 Jed Latkin Former Chief Operating Officer 350.0K 80.0K 1.32M 27.2K 1.77M 74.20%
3 2024 Robert Morse Former Chief Financial Officer 126.8K 126.8K 0.00%
4 2023 Ted Karkus Chief Executive Officer 675.0K 200.0K 2.47M 27.2K 3.37M 73.21%
5 2023 Robert Morse Former Chief Financial Officer 275.0K 19.9K 246.5K 541.4K 45.53%
6 2023 Monica Brady Former Chief Accounting Officer 200.0K 10.7K 210.7K 0.00%
7 2022 Bill White Former Chief Financial Officer 147.6K 1.64M 101.9K 1.89M 86.79%
8 2022 Ted Karkus Chief Executive Officer 675.0K 200.0K 27.2K 902.2K 0.00%
9 2022 Monica Brady Former Chief Accounting Officer 200.0K 10.7K 210.7K 0.00%
10 2021 Ted Karkus Chairman of the Board and Chief Executive Officer 590.0K 325.0K 26.4K 941.4K 0.00%
11 2021 Ted Karkus Chief Executive Officer 590.0K 325.0K 26.4K 941.4K 0.00%
12 2021 Monica Brady Chief Financial Officer 173.2K 50.0K 10.7K 233.9K 0.00%
13 2021 Monica Brady Former Chief Accounting Officer 173.2K 50.0K 10.7K 233.9K 0.00%
14 2020 Ted Karkus Chairman of the Board and Chief Executive Officer 125.0K 300.0K 20.0K 445.0K 0.00%
15 2020 Monica Brady Chief Financial Officer 142.0K 60.0K 163.5K 11.1K 376.6K 43.42%
16 2019 Monica Brady Chief Financial Officer 142.0K 35.0K 76.1K 10.6K 263.7K 28.88%
17 2019 Ted Karkus Chairman of the Board and Chief Executive Officer 125.0K 100.0K 24.0K 249.0K 0.00%
18 2018 Ted Karkus Chairman of the Board and Chief Executive Officer 209.7K 100.0K 1.55M 26.0K 1.89M 82.24%
19 2018 Monica Brady Chief Financial Officer 132.0K 30.0K 65.7K 11.5K 239.1K 27.45%
20 2017 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 725.0K 458.1K 25.8K 1.88M 24.32%
21 2017 Robert V. Cuddihy, Jr Former Chief Financial Officer and Chief Operating Officer 247.1K 677.3K 924.5K 0.00%
22 2017 Monica Brady Chief Accounting Officer 113.3K 60.0K 18.4K 11.9K 203.6K 9.05%
23 2017 Monica Brady Chief Financial Officer 113.3K 60.0K 18.4K 11.9K 203.6K 9.05%
24 2016 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 150.0K 25.6K 850.6K 0.00%
25 2016 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 350.0K 75.0K 25.6K 450.6K 0.00%
26 2016 Robert V. Cuddihy, Jr Former Chief Financial Officer and Chief Operating Officer 350.0K 75.0K 25.6K 450.6K 0.00%
27 2015 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 160.0K 25.6K 860.6K 0.00%
28 2015 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 350.0K 85.0K 25.6K 460.6K 0.00%
29 2014 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 30.0K 139.0K 23.8K 867.8K 16.02%
30 2014 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 350.0K 85.0K 23.5K 23.8K 482.3K 4.88%
31 2013 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 100.0K 82.5K 55.1K 45.5K 958.1K 14.37%
32 2013 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 350.0K 50.0K 66.2K 45.5K 511.6K 12.93%
33 2012 Ted Karkus Chairman of the Board and Chief Executive Officer 675.0K 225.0K 81.3K 43.0K 1.02M 7.93%
34 2012 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 350.0K 100.0K 43.0K 493.0K 0.00%
35 2011 Ted Karkus Chairman of the Board and Chief Executive Officer 703.3K 150.0K 44.4K 900.8K 16.65%
36 2011 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 275.0K 37.5K 87.5K 44.3K 444.3K 19.69%
37 2010 Ted Karkus Chairman of the Board and Chief Executive Officer 750.0K 150.0K 399.8K 47.5K 1.35M 40.81%
38 2010 Robert V. Cuddihy, Jr. Chief Financial Officer, Executive Vice President and Chief Operating Officer 275.0K 75.0K 50.0K 124.4K 47.4K 571.7K 30.50%
39 2010 Robert V. Cuddihy, Jr. Interim Chief Financial Officer, Executive Vice President and Chief Operating Officer 275.0K 75.0K 50.0K 2.0K 47.4K 449.3K 11.57%
40 2009 Guy J. Quigley Former Chairman of the Board, President, Chief Executive Officer 446.2K 53.2K 499.4K 0.00%
41 2009 Ted Karkus Chairman of the Board and Chief Executive Officer 369.3K 87.5K 25.3K 482.1K 0.00%
42 2009 Gerard M. Gleeson Former Vice President and Chief Financial Officer 218.8K 103.3K 322.1K 0.00%
43 2009 Charles A. Phillips Former Executive Vice President and Chief Operating Officer 285.8K 24.8K 310.6K 0.00%
44 2009 Robert V. Cuddihy, Jr. Interim Chief Financial Officer, Executive Vice President and Chief Operating Officer 128.0K 27.5K 23.1K 35.9K 214.5K 10.76%
45 2008 Guy J. Quigley Chairman of the Board, President, Chief Executive Officer 977.0K 18.8K 50.3K 1.05M 0.00%
46 2008 Guy J. Quigley Former Chairman of the Board, President, Chief Executive Officer 977.0K 18.8K 50.3K 1.05M 0.00%
47 2008 Charles A. Phillips Executive Vice President, Chief Operating Officer 703.0K 13.5K 47.2K 763.7K 0.00%
48 2008 Charles A. Phillips Former Executive Vice President and Chief Operating Officer 703.0K 13.5K 47.2K 763.7K 0.00%
49 2008 George J. Longo Vice President, Chief Financial Officer retired on 9-05-2008 385.0K 36.0K 421.0K 0.00%
50 2008 Gerard M. Gleeson Former Vice President and Chief Financial Officer 179.2K 3.8K 37.6K 220.6K 0.00%
51 2008 Gerard M. Gleeson Vice President, Chief Financial Officer 179.2K 3.8K 37.6K 220.6K 0.00%
52 2007 Guy J. Quigley Former Chairman of the Board, President, Chief Executive Officer 905.0K 395.9K 49.7K 1.35M 0.00%
53 2007 Guy J. Quigley Chairman of the Board, President, Chief Executive Officer 905.0K 395.9K 49.7K 1.35M 0.00%
54 2007 Charles A. Phillips Former Executive Vice President and Chief Operating Officer 651.0K 284.8K 47.2K 983.0K 0.00%
55 2007 Charles A. Phillips Executive Vice President, Chief Operating Officer 651.0K 284.8K 47.2K 983.0K 0.00%
56 2007 George J. Longo Vice President, Chief Financial Officer retired on 9-05-2008 447.0K 195.6K 44.5K 687.1K 0.00%
57 2006 Guy J. Quigley Chairman of the Board, President, Chief Executive Officer 838.0K 73.3K 45.7K 957.1K 0.00%
58 2006 Charles A. Phillips Executive Vice President, Chief Operating Officer 617.8K 52.8K 45.6K 716.2K 0.00%
59 2006 George J. Longo Vice President, Chief Financial Officer retired on 9-05-2008 414.0K 36.2K 41.3K 491.6K 0.00%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-10-31 DEF 14A
2025-10-21 PRE 14A
2025-08-19 DEFA14A
2025-08-15 DEF 14A
2025-07-28 PRE 14A
2025-06-23 DEF 14A
2024-05-15 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-15 NT 10-Q
2026-03-27 NT 10-K
2026-02-13 8-K
2026-02-13 8-K
2026-01-27 8-K
2026-01-23 8-K
2026-01-23 8-K
2026-01-23 25-NSE
2026-01-09 8-K
2026-01-09 8-K

Executive team

NameTitleCompensationGender
Ted William Karkus Chairman & Chief Executive Officer 903.2K male
Jason Karkus President of Nebula Genomics male
Kevin Quinn Chief Product Officer of Nebula Genomics male
ESG Rating
B+
DRUG MANUFACTURERS - SPECIALTY & GENERIC
2017
E (Environmental)
85.5 / 66.0
Company / Sector avg.
S (Social)
78.8 / 70.0
Company / Sector avg.
G (Governance)
71.7 / 66.6
Company / Sector avg.
ESG Total
78.7 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits